Rubric Capital Management LP's Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Aug 1, 2022
- Accession no.
- 0001104659-22-084850
- Filed
- Aug 1, 2022, 6:11 PM ET
- Trade date
- Jul 29, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $15.0M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rubric Capital Management LPCIK 0001687509 | 10% Owner |
| Rosen David EfraimCIK 0001898677 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock, par value $0.001 per share ("Common Stock") | PPurchaseAcquired | +565,000 | $4.72 | +$2,666,800 | 1,721,953 | Indirect | |
| Jul 29, 2022 | Series A Preferred Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $822.21 | +$12,333,150 | 15,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.